| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |